Kaposi Sarcoma-Associated Herpesvirus Risk and Disease in Kidney Donors and Transplant Recipients with HIV in the United States

By sjmartinez • May 6, 2025

Nambiar P, Liang T, Labo N, Hand J, Blumberg EA, Rana MM, Florman S, Haydel B, Morris MI, Schaenman J, Rodrigues MMS, Werbel WA, Bowring MG, Friedman-Moraco RJ, Stock P, Stosor V, Mehta S, Gilbert AJ, Elias N, Mehta SA, Small CB, Haidar G, Malinis M, Pereira MR, Aslam S, Wojciechowski D, La Hoz R, Santos CAQ, Apewokin S, Castillo-Lugo JA, Ranganna K, Morsheimer M, Massie A, Segev DL, Miley W, Marshall V, Whitby D, Tobian AAA, Durand CM. Kaposi Sarcoma-Associated Herpesvirus Risk and Disease in Kidney Donors and Transplant Recipients with HIV in the United States. Clin Infect Dis. 2025 May 5:ciaf229. doi: 10.1093/cid/ciaf229. Epub ahead of print. PMID: 40324947.

Tags: HHV8 seroprevalence, HIV, HOPE Act, Human Herpesvirus 8, Infectious Diseases, Kaposi sarcoma, KSHV seroprevalence, Organ transplantation, Publications

Factors associated with cervical cancer screening: results from cross-sectional surveys in Kenya and Malawi

Moucheraud C, Chibaka S, Golub G, Kalande P, Makwaya A, Ochieng E, Ogutu V, Phiri K, Phiri S, Hoffman RM. Factors associated with cervical cancer[...]

Risks for sudden cardiac and undetermined cause of death among people with HIV in the reprieve primary cardiovascular prevention trial

deFilippi C, Awwad A, Bloomfield GS, Weir IR, Ribaudo H, Zanni MV, Fichtenbaum CJ, Malvestutto CD, Aberg JA, Diggs MR, Chu SM, Paradis K, MacArthur[...]

rLVS(delta) capB/Yp F1-V single vector platform vaccine expressing Yersinia pestis F1 and LcrV antigens provides complete protection against lethal respiratory challenge with virulent plague bacilli

Jia Q, Bowen RA, Masleša-Galić S, Horwitz MA. rLVS ΔcapB/Yp F1-V single vector platform vaccine expressing Yersinia pestis F1 and LcrV antigens provides complete protection against lethal[...]